386 related articles for article (PubMed ID: 27914109)
21. Identification of SHCBP1 as a novel downstream target gene of SS18-SSX1 and its functional analysis in progression of synovial sarcoma.
Peng C; Zhao H; Chen W; Song Y; Wang X; Li J; Qiao Y; Wu D; Ma S; Wang X; Gao C
Oncotarget; 2016 Oct; 7(41):66822-66834. PubMed ID: 27572315
[TBL] [Abstract][Full Text] [Related]
22. BCOR-CCNB3 Fusion Positive Sarcomas: A Clinicopathologic and Molecular Analysis of 36 Cases With Comparison to Morphologic Spectrum and Clinical Behavior of Other Round Cell Sarcomas.
Kao YC; Owosho AA; Sung YS; Zhang L; Fujisawa Y; Lee JC; Wexler L; Argani P; Swanson D; Dickson BC; Fletcher CDM; Antonescu CR
Am J Surg Pathol; 2018 May; 42(5):604-615. PubMed ID: 29300189
[TBL] [Abstract][Full Text] [Related]
23. BCOR-CCNB3-positive soft tissue sarcoma with round-cell and spindle-cell histology: a series of four cases highlighting the pitfall of mimicking poorly differentiated synovial sarcoma.
Li WS; Liao IC; Wen MC; Lan HH; Yu SC; Huang HY
Histopathology; 2016 Nov; 69(5):792-801. PubMed ID: 27228320
[TBL] [Abstract][Full Text] [Related]
24. The SS18-SSX Oncoprotein Hijacks KDM2B-PRC1.1 to Drive Synovial Sarcoma.
Banito A; Li X; Laporte AN; Roe JS; Sanchez-Vega F; Huang CH; Dancsok AR; Hatzi K; Chen CC; Tschaharganeh DF; Chandwani R; Tasdemir N; Jones KB; Capecchi MR; Vakoc CR; Schultz N; Ladanyi M; Nielsen TO; Lowe SW
Cancer Cell; 2018 Mar; 33(3):527-541.e8. PubMed ID: 29502955
[TBL] [Abstract][Full Text] [Related]
25. BCOR Overexpression Is a Highly Sensitive Marker in Round Cell Sarcomas With BCOR Genetic Abnormalities.
Kao YC; Sung YS; Zhang L; Jungbluth AA; Huang SC; Argani P; Agaram NP; Zin A; Alaggio R; Antonescu CR
Am J Surg Pathol; 2016 Dec; 40(12):1670-1678. PubMed ID: 27428733
[TBL] [Abstract][Full Text] [Related]
26. Gene expression profiles relate to SS18/SSX fusion type in synovial sarcoma.
Fernebro J; Francis P; Edén P; Borg A; Panagopoulos I; Mertens F; Vallon-Christersson J; Akerman M; Rydholm A; Bauer HC; Mandahl N; Nilbert M
Int J Cancer; 2006 Mar; 118(5):1165-72. PubMed ID: 16152617
[TBL] [Abstract][Full Text] [Related]
27. Recurrent and novel SS18-SSX fusion transcripts in synovial sarcoma: description of three new cases.
Przybyl J; Sciot R; Rutkowski P; Siedlecki JA; Vanspauwen V; Samson I; Debiec-Rychter M
Tumour Biol; 2012 Dec; 33(6):2245-53. PubMed ID: 22976541
[TBL] [Abstract][Full Text] [Related]
28. A poorly differentiated synovial sarcoma arising from the pulmonary valve.
Yin L; Chen M; Ye F; Bu H; Bai H; Yu J; Zhang H
Cardiovasc Pathol; 2013; 22(6):501-2. PubMed ID: 23701986
[TBL] [Abstract][Full Text] [Related]
29. Release of circulating tumor cells and cell-free nucleic acids is an infrequent event in synovial sarcoma: liquid biopsy analysis of 15 patients diagnosed with synovial sarcoma.
Mihály D; Nagy N; Papp G; Pápai Z; Sápi Z
Diagn Pathol; 2018 Oct; 13(1):81. PubMed ID: 30326929
[TBL] [Abstract][Full Text] [Related]
30. MDM2 amplification and fusion gene ss18-ssx in a poorly differentiated synovial sarcoma: A rare but puzzling conjunction.
Di Mauro I; Mescam-Mancini L; Chetaille B; Lae M; Pierron G; Dadone-Montaudie B; Bazin A; Bouvier C; Michiels JF; Pedeutour F
Neoplasia; 2020 Aug; 22(8):311-321. PubMed ID: 32559641
[TBL] [Abstract][Full Text] [Related]
31. Truncated SSX protein suppresses synovial sarcoma cell proliferation by inhibiting the localization of SS18-SSX fusion protein.
Yoneda Y; Ito S; Kunisada T; Morimoto Y; Kanzaki H; Yoshida A; Shimizu K; Ozaki T; Ouchida M
PLoS One; 2013; 8(10):e77564. PubMed ID: 24130893
[TBL] [Abstract][Full Text] [Related]
32. Clinical impact of molecular and cytogenetic findings in synovial sarcoma.
Panagopoulos I; Mertens F; Isaksson M; Limon J; Gustafson P; Skytting B; Akerman M; Sciot R; Dal Cin P; Samson I; Iliszko M; Ryoe J; Dêbiec-Rychter M; Szadowska A; Brosjö O; Larsson O; Rydholm A; Mandahl N
Genes Chromosomes Cancer; 2001 Aug; 31(4):362-72. PubMed ID: 11433527
[TBL] [Abstract][Full Text] [Related]
33. Characterization of a variant SYT-SSX1 synovial sarcoma fusion transcript.
Safar A; Wickert R; Nelson M; Neff JR; Bridge JA
Diagn Mol Pathol; 1998 Oct; 7(5):283-7. PubMed ID: 9990487
[TBL] [Abstract][Full Text] [Related]
34. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.
Ladanyi M; Antonescu CR; Leung DH; Woodruff JM; Kawai A; Healey JH; Brennan MF; Bridge JA; Neff JR; Barr FG; Goldsmith JD; Brooks JS; Goldblum JR; Ali SZ; Shipley J; Cooper CS; Fisher C; Skytting B; Larsson O
Cancer Res; 2002 Jan; 62(1):135-40. PubMed ID: 11782370
[TBL] [Abstract][Full Text] [Related]
35. Histology and grading are important prognostic factors in synovial sarcoma.
Bianchi G; Sambri A; Righi A; Dei Tos AP; Picci P; Donati D
Eur J Surg Oncol; 2017 Sep; 43(9):1733-1739. PubMed ID: 28579008
[TBL] [Abstract][Full Text] [Related]
36. The diagnostic utility of reduced immunohistochemical expression of SMARCB1 in synovial sarcomas: a validation study.
Ito J; Asano N; Kawai A; Yoshida A
Hum Pathol; 2016 Jan; 47(1):32-7. PubMed ID: 26520417
[TBL] [Abstract][Full Text] [Related]
37. Novel SYT-SSX fusion transcript variants in synovial sarcoma.
Dimitriadis E; Rontogianni D; Kyriazoglou A; Takou A; Frangia K; Pandis N; Trangas T
Cancer Genet Cytogenet; 2009 Nov; 195(1):54-8. PubMed ID: 19837269
[TBL] [Abstract][Full Text] [Related]
38. The synovial-sarcoma-associated SS18-SSX2 fusion protein induces epigenetic gene (de)regulation.
de Bruijn DR; Allander SV; van Dijk AH; Willemse MP; Thijssen J; van Groningen JJ; Meltzer PS; van Kessel AG
Cancer Res; 2006 Oct; 66(19):9474-82. PubMed ID: 17018603
[TBL] [Abstract][Full Text] [Related]
39. A clinicopathologic study on SS18 fusion positive head and neck synovial sarcomas.
Owosho AA; Estilo CL; Rosen EB; Yom SK; Huryn JM; Antonescu CR
Oral Oncol; 2017 Mar; 66():46-51. PubMed ID: 28249647
[TBL] [Abstract][Full Text] [Related]
40. Utility of Immunohistochemistry With Antibodies to SS18-SSX Chimeric Proteins and C-Terminus of SSX Protein for Synovial Sarcoma Differential Diagnosis.
Lasota J; Chłopek M; Kaczorowski M; Natálie K; Ryś J; Kopczyński J; Sulaieva O; Michal M; Kruczak A; Harazin-Lechowska A; Szczepaniak M; Koshyk O; Hałoń A; Czapiewski P; Abdullaev Z; Kowalik A; Aldape KD; Michal M; Miettinen M
Am J Surg Pathol; 2024 Jan; 48(1):97-105. PubMed ID: 37899499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
